智通财经APP讯，微创机器人-B(02252)发布公告，集团自主研发的图迈®腔镜手术机器人远程手术全科室应用(图迈远程)获得国家药品监督管理局(NMPA)的注册批准，成为全球首个获批可应用于全科室远程手术的腔镜手术机器人。
远程手术技术，是公司多年来持续攻克并重点研发的方向之一，是对公司“让天下没有难做的手术”初心的践行。本次图迈远程获得NMPA批准，是引领全球机器人领域技术与应用发展的里程碑式突破，将开启全球远程外科产业化新篇章，标志着全球外科手术正式进入远程手术时代。同时，图迈远程的获证将使集团的产品组合进一步丰富和多元，图迈系列机器人已实现多孔、单孔、远程一体化兼容，可为医院和医生提供腔镜手术机器人系统智能化全解方案，将有助于提升集团机器人产品组合在全球市场的竞争力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.